Claudia Blattner
Corporate Officer/Principal at IMMATICS N.V.
Network origin in Claudia Blattner first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 26 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Claudia Blattner via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer Founder Director of Finance/CFO Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Chairman Director/Board Member Director/Board Member Chief Executive Officer Founder Director/Board Member Director/Board Member Founder Chief Tech/Sci/R&D Officer | |
| Eberhard Karls Universität Tübingen | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| dievini Verwaltungs GmbH | Chief Executive Officer Chief Executive Officer Chief Executive Officer | ||
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member Director/Board Member | |
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Chief Executive Officer Chairman Director/Board Member | |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Private Equity Investor Founder Chief Executive Officer | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Chief Executive Officer Director/Board Member | |
| Febit, Inc. | Director/Board Member Chairman | ||
| INFLARX N.V. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Investor Relations Contact General Counsel | |
| University of Mannheim | College/University | Undergraduate Degree Graduate Degree | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Chairman Director/Board Member | |
| CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
febit holding GmbH
 febit holding GmbH Medical/Nursing ServicesHealth Services febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany. | Medical/Nursing Services | Director/Board Member Chairman | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member Director/Board Member | |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Medical Specialties | Chairman Director/Board Member | |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| PARK & BELLHEIMER AG | Beverages: Alcoholic | Chairman | |
| Nationaltheater Mannheim Foundation | Director/Board Member | ||
| Julius-Maximilians-Universität Würzburg | College/University | Doctorate Degree | |
RITTERSHAUS Management und Beteiligungs GmbH
 RITTERSHAUS Management und Beteiligungs GmbH Miscellaneous Commercial ServicesCommercial Services RITTERSHAUS Management und Beteiligungs GmbH provides management services. The private company is based in Mannheim, Germany. The CEO of the German company is Christof Hettich. | Miscellaneous Commercial Services | Chief Executive Officer | |
| JUPEC Verlags GmbH | President | ||
| Stiftung ProJustitia | Chairman | ||
| RITTERSHAUS Steuerberatungsgesellschaft mbH | Chief Executive Officer | ||
| Bohlini GmbH & Co. KG | President | ||
SRH Kliniken GmbH
 SRH Kliniken GmbH Hospital/Nursing ManagementHealth Services Part of SRH Holding (SdbR), SRH Kliniken GmbH is a healthcare company that operates multiple clinics across Germany, including locations in Gera, Karlsbad-Langensteinbach, Bad Wimpfen, Neresheim, Oberndorf a.N., Bad Kösen, and others. The company is based in Heidelberg, Germany. The company provides medical services and treatments to patients in these regions. The CEO of the company is Werner Stalla. | Hospital/Nursing Management | Chairman | |
RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB
 RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB Miscellaneous Commercial ServicesCommercial Services RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB is a law firm based in Mannheim, Germany. The German company has a unique perspective on the legal world and operates differently from traditional law firms. The private company's description emphasizes its distinctiveness and alternative approach to legal services. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
InterComponentWare AG
 InterComponentWare AG Packaged SoftwareTechnology Services InterComponentWare AG provides technology solutions for the healthcare market. Its products include ICW Master Patient Index, ICW Professional Exchange Server and ICW Care Manager. The firm serves the hospitals, care providers and care management companies. The company was founded in October 26, 1998 and is headquartered in Walldorf, Germany. | Packaged Software | Chairman | |
NewMarket Venture Verwaltungs GmbH
 NewMarket Venture Verwaltungs GmbH Miscellaneous Commercial ServicesCommercial Services NewMarket Venture Verwaltungs GmbH provides management services. The private company is based in Mannheim, Germany. The German company was founded in 2000. The CEO is Christof Hettich. | Miscellaneous Commercial Services | Chief Executive Officer | |
Actris AG
 Actris AG Food DistributorsDistribution Services Actris Ag's develops and manages real estate properties. The firm also produces and distributes beer. The company is headquartered in Mannheim, Germany | Food Distributors | Chairman | |
LTS LOHMANN Therapie-Systeme AG
 LTS LOHMANN Therapie-Systeme AG Pharmaceuticals: MajorHealth Technology LTS LOHMANN Therapie-Systeme AG manufactures transdermal therapeutic systems and oral thin films. The firm's product range encompasses oral active ingredient films, nicotine patches, and pharmaceutical drugs in dosage forms. Its service areas cover clinical trials, laboratory testing, and research and development projects. The company was founded in 1984 and is headquartered in Andernach, Germany. | Pharmaceuticals: Major | Chairman | |
| ARYA SCIENCES ACQUISITION CORP V | Financial Conglomerates | Founder | |
| Princeton University | College/University | Undergraduate Degree | |
| SOLID BIOSCIENCES INC. | Biotechnology | Director/Board Member | |
Perceptive Advisors (Private Equity)
 Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors (Private Equity) (Perceptive Advisors) is a private equity subsidiary of Perceptive Advisors LLC founded in 1999 by Joseph Eric Edelman. The firm is headquartered in New York. | Investment Managers | Chief Investment Officer | |
Xontogeny LLC
 Xontogeny LLC Pharmaceuticals: MajorHealth Technology Xontogeny LLC operates biotech aggregator company. The firm offers entrepreneurs with guidance and operational support in drug and technology development. The company was founded by Christopher Nishan Garabedian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| Germany | 33 |
| United States | 14 |
| United Kingdom | 3 |
| Switzerland | 2 |
| France | 2 |
Sectoral
| Health Technology | 20 |
| Finance | 9 |
| Commercial Services | 7 |
| Consumer Services | 5 |
| Technology Services | 3 |
Operational
| Director/Board Member | 124 |
| Chairman | 49 |
| Corporate Officer/Principal | 45 |
| Chief Executive Officer | 45 |
| Independent Dir/Board Member | 25 |
Most connected contacts
| Insiders | |
|---|---|
| Christof Hettich | 40 |
| Friedrich von Bohlen und Halbach | 36 |
| Eliot Forster | 35 |
| Peter Chambré | 23 |
| Mathias Hothum | 19 |
| Adam Stone | 18 |
| Carsten Reinhardt | 16 |
| Michael Atieh | 16 |
| Arnd Christ | 15 |
| Heather Mason | 13 |
| Paul Carter | 12 |
| Rainer Kramer | 10 |
| Nancy Valente | 8 |
| Jordan Silverstein | 7 |
| Edward Sturchio | 5 |
- Stock Market
- Insiders
- Claudia Blattner
- Company connections
